APA استشهاد

Knappskog, S., Berge, E. O., Chrisanthar, R., Geisler, S., Staalesen, V., Leirvaag, B., . . . Lønning, P. E. (2015). Concomitant inactivation of the p53‐ and pRB‐ functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo. Mol Oncol.

استشهاد بنمط شيكاغو

Knappskog, Stian, et al. "Concomitant Inactivation of the P53‐ and PRB‐ Functional Pathways Predicts Resistance to DNA Damaging Drugs in Breast Cancer In vivo." Mol Oncol 2015.

MLA استشهاد

Knappskog, Stian, et al. "Concomitant Inactivation of the P53‐ and PRB‐ Functional Pathways Predicts Resistance to DNA Damaging Drugs in Breast Cancer In vivo." Mol Oncol 2015.

تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.